1 Article(s)Download |
PMID | Title | Journal | Pub. Date | #Total Relationship(s) |
| 1 | 21493750 | JNJ-26070109 [(R)4-bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: a novel, potent, and selective cholecystokinin 2 receptor antagonist with good oral bioavailability. | J Pharmacol Exp Ther | 2011 Jul | 1 |